To Prevent-
1904 generics available
This combination gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
1904 generics available
Adefovir Dipivoxil is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
1904 generics available
Intravenous Adenosine is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).
1904 generics available
This eye drops is used for the treatment of lens opacification.
1904 generics available
To Prevent-
1904 generics available
To Prevent-
1904 generics available
To Prevent-
1904 generics available
To Prevent-
1904 generics available
To Prevent-
1904 generics available
To Prevent-
1904 generics available
Ledipasvir and Sofosbuvir combination is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
1904 generics available
Lefamulin Acetate is indicated for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
1904 generics available
Leflunomide is indicated in adults for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms and to retard structural damage as manifested by x-ray erosions and joint space narrowing.
1904 generics available
Multiple Myeloma: Lenalidomide in combination with Dexamethasone is indicated for the treatment of adult patients with multiple myeloma (MM). Lenalidomide is indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT).
Myelodysplastic Syndromes: Lenalidomide is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
Mantle Cell Lymphoma: Lenalidomide is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included Bortezomib.
Follicular Lymphoma: Lenalidomide in combination with a Rituximab product, is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL).
Marginal Zone Lymphoma: Lenalidomide in combination with a Rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).
Limitations of Use: Lenalidomide is not indicated and is not recommended for the treatment of patients with CLL outside of controlled clinical trials.
1904 generics available
Lenograstim is indicated in adults, adolescents and children aged older than 2 years for:
1904 generics available
Lenvatinib is a kinase inhibitor that is indicated:
1904 generics available
Lercanidipine is indicated for the treatment of mild to moderate essential hypertension.
1904 generics available
1904 generics available
Prostate Cancer: 3 Month 11.25 mg is indicated in the palliative treatment of advanced prostatic cancer. It offers an alternative treatment of prostatic cancer when orchiectomy or estrogen administration are either not indicated or unacceptable to the patient.
Endometriosis: 3 month 11.25 mg is indicated in the treatment of endometriosis for a period of six months. It can be used as sole therapy or as an adjunct to surgery.
Uterine Fibroids: 3 month 11.25 mg is also indicated in the treatment of leiomyoma uteri (uterine fibroids) for a period up to six months. Therapy may be preoperative prior to myomectomy or hysterectomy, or it may provide symptomatic relief for the perimenopausal woman who does not desire surgery.
Breast Cancer: 3 month 11.25 mg is also indicated for the treatment of breast cancer in pre- and peri-menopausal women in whom hormone therapy is specified.
1904 generics available